Pain in the mark: India's Nucynta vs Lucynta tug-of-war
This article was originally published in Scrip
Executive Summary
An Indian court has stayed the operation of a restraining order against Lupin in a trademark suit over its version of Johnson & Johnson's pain drug, Nucynta (tapentadol).